Folia Medica Cracoviensia

1. Hau T.: The History of Peritonitis. Acta Chirurgica Austriaca. 2000; 32: 157–161.
2. Hau T.: Biology and treatment of peritonitis: the historic development of current concepts. J Am Coll Surg 1998; 186: 475–484.
3. Recklinghausen F.v.: Zur Fettresorption. Archiv f pathol Anat. 1863; 26: 172–208. https://doi.org/10.1007/BF01930770.
4. Wegner G.: Chirurgische Bermekungen über die Peritonealhöle, mit besonderer Berucksichtigung der Ovariotomie. Arch Klin Chir. 1877; 20: 51–145.
5. Curtis B.F.: I. The Pathology of Peritonitis. Ann Surg. 1887; 5 (2): 120–124. doi: 10.1097/00000658-188701000-00026.
6. Dubar L., Remy Ch.: Sur l’absorption par le péritoine. Journal de l’anatomie et de la physiologie normales et pathologiques de l’homme et des animaux. 1882; 18: 60–106, 342–372.
7. Grawitz P.: Statistischer und experimentell-pathologischer Beitrag zur Kenntnis der Peritonitis. Charité-Annalen. 1886; 11: 770–823.
8. Grawitz P.: Beitrag zur Theorie der Eiterung. Virchows Archiv. 1889; 116: 116–153.
9. Guzek J.W.: Karol Klecki (1866–1931). Acta Phisiologica Polonia. 1987; 38: 272–278.
10. Klecki C.: Recherches sur la pathogénie de la péritonite d’origine intestinale; étudo de la virulence du coli bacille. Annales de l’Institut Pasteur. Paris. 1895; 9: 710–735.
11. Laruelle L.: Etude bacteriologique sur les peritonitis par perforation. Le Cellule. 1889; 5: 61–122.
12. Pawlowsky A.D.: Zur Lehre von der Aetiologie, der Entstehungsweise und den Formen der acuten Peritonitis. Virchows Archiv. 1889; 117: 469–530.
13. Barbacci O.: Sulla etiologia e patogenesi delle peritonite da perforatione. Studio anatomico e sperimentale. La Sperimentale. 1893: 4, 15.
14. Malvoz E.: Le bacterium coli commune comme agent habituel des peritonitis d’origine intestinale. Archive de medicine Experimentale et d’anatomie Pathologique. 1891; 3: 593–614.
15. Ziegler P.: Studien ueber die intestiale Form der Peritonitis. Munich 1893. 16. Treves F.: An Address On Some Rudiments Of Intestinal Surgery. BMJ 1898; 2 (1975): 1385–1390. https://www.jstor.org/stable/20256576.
17. Neisser M.: Ueber die Durchgängigkeit der Darmwand für Bakterien. Zeitschr f Hygiene. 1896; 22: 12–32. https://doi.org/10.1007/BF02288370.
18. Weil S.: Die akute freie Peritonitis [in:] E. Payr et al. (eds.) Ergebnisse der Chirurgie und Orthopädie. 1911; 2: 278–357.
19. Lartigau A.J.: The Bacillus Coli Communis in Human Infections. Journal AMA. 1902; 38 (15): 930– 937.
20. Dudgeon L., Sargant P.: The Bacteriology of Peritonitis. London 1905.
21. Hertzler A.: The Peritoneum. St Louis: Mosby. 1912; 2: 36.
22. Meleney F.L., Harvey H.D., Jern H.Z.: Peritonitis: I. The Correlation of The Bacteriology of The Peritoneal Exudate and The Clinical Course of The Disease in One Hundred and Six Cases of Peritonitis. Arch Surg. 1931; 22 (1): 1–66.
23. Haas W.: Über den Bakteriengehalt des Pfortaderblutes und die Entstehung von Leberabszessen. Deutsche Zeitschrift f Chirurgie. 1922; 173: 239–293.
24. Dieulafoy G.: A Text-book of medicine. New York. 1912; 1: 780.

1. Donner R.S., Bickley H.: Problem-based learning in American medical education: an overview. Bull Med Libr Assoc. 1993 Jul; 81 (3): 294–298.
2. Schafer M., Georg W., Muhlinghaus I., Frohmel A., Rolle D., Pruskil S., Heinz A., Burger W.: Experience with new teaching methods and testing in psychiatric training. Nervenarzt. 2007 Mar; 78 (3): 283–293.
3. Neville A.J.: Problem-based learning and medical education forty years on. Med Princ Pract. 2009; 18 (1): 1–9.
4. Cendan J.C., Silver M., Ben-David K.: Changing the student clerkship from traditional lectures to small group casebased. J Surg Educ. 2011; 68 (2): 117–120.
5. Skrzypek A., Stalmach-Przygoda A., Dębicka-Dąbrowska D., Kocurek A., Szopa M., Górski S., Szeliga M., Małecki Ł., Grodecka A., Cebula G., Nowakowski M.: Wybrane metody dydaktyczne stosowane w edukacji studentów medycyny w Zakładzie Dydaktyki Medycznej Uniwersytetu Jagiellońskiego Collegium Medicum. Co nowego w dydaktyce medycznej? General and Professional Education. 2018; 1: 26–32.
6. Skrzypek A., Szeliga M., Jagielski P., Perera I., Dębicka-Dąbrowska D., Wilczyńska-Golonka M.: The modified Peyton approach in the teaching of cardiac auscultation. Folia Med Crac. 2019; 59 (4): 21–32.
7. Oliveira L.B., Díaz L.J., Carbogim F. da C., Rodrigues A.R., Püschel V.A.: Effectiveness of teaching strategies on the development of critical thinking in undergraduate nursing students: a meta-analysis. Rev Esc Enferm USP. 2016 Apr; 50 (2): 355–364.
8. Kong L.N., Qin B., Zhou Y.Q., Mou S.Y., Gao H.M.: The effectiveness of problem-based learning on development of nursing students’ critical thinking: a systematic review and meta-analysis. Int J Nurs Stud. 2014 Mar; 51 (3): 458–469.
9. Yuan H., Williams B.A., Fan L.: A systematic review of selected evidence on developing nursing students’ critical thinking through problem-based learning. Nurse Educ Today. 2008 Aug; 28 (6): 657–663. doi: 10.1016/j.nedt.2007.12.006. Epub 2008 Feb 11. Review.
10. Zahid M.A., Varghese R., Mohammed A.M., Ayed A.K.: Comparison of the problem based learning- driven with the traditional didactic-lecture-based curricula. Int J Med Educ. 2016 Jun 12; 7: 181–187. doi: 10.5116/ijme.5749.80f5.
11. Ibrahim N.K., Banjar S., Al-Ghamdi A., Al-Darmasi M., Khoja A., Turkistani J., Arif R., Al-Sebyani A., Musawa A.A., Basfar W.: Medical students preference of problem-based learning or traditional lectures in King Abdulaziz University, Jeddah, Saudi Arabia. Ann Saudi Med. 2014 Mar–Apr; 34 (2): 128–133.
12. Surif J., Ibrahim H., Mokhtar M.: Implementation of Problem Based Learning in Higher Education Institutions and Its Impact on Students’ Learning 4th. Int Symp Probl Learn 2013. 2013; 66–71.
13. Arneson H., Ekberg K.: Evaluation of empowerment processes in a workplace health promotion intervention based on learning in Sweden. Health Promot Int. 2005 Dec; 20 (4): 351–359. Epub 2005 Sep 16.
14. Susskind J.E.: Powerpoint’s Power in the Classroom: Enhancing Students’ Self-Efficacy and Attitudes. Computers and Education. 2005 Sep; v45 n2: 203–215.
15. DeBord K.A., Aruguete M.S., Muhlig J.: Are Computer-Assisted Teaching Methods Effective? Teaching of Psychology. 2004; 31 (1): 65–68.
16. Nouri H., Shahid A.: The effect of Powerpoint presentations on student learning and attitudes. Glob Perspect Account Educ. 2005; 2: 53–73.
17. Atta I.S., Alghamdi A.H.: The efficacy of self-directed learning versus problem-based learning for teaching and learning ophthalmology: a comparative study. Adv Med Educ Pract. 2018 Sep 4; 9: 623–630.
18. Chang B.J.: Problem-based learning in medical school: A student’s perspective. Ann Med Surg (Lond). 2016 Nov; 22; 12: 88–89.
19. Skrzypek A., Cegielny T., Szeliga M., Jabłoński K., Nowakowski M.: Different perceptions of Problem Based Learning among Polish and Scandinavian students. Is PBL the same for everyone? Preliminary study. General and Professional Education. 2017; 3: 58–64. ISSN 2084-1469.
20. Ibrahim M.E., Al-Shahrani A.M., Abdalla M.E., Abubaker I.M., Mohamed M.E.: The Effectiveness of Problem-based Learning in Acquisition of Knowledge, Soft Skills During Basic and Preclinical Sciences: Medical Students’ Points of View. Acta Inform Med. 2018 Jun; 26 (2): 119–124.
21. Skrzypek A., Perera I., Szeliga M., Jagielski P., Dębicka-Dąbrowska D., Wilczyńska-Golonka M., Górecki T., Cebula G.: The modified Peyton’s approach and students’ learning style. Folia Med Crac. 2020; 60 (2): 67–80.

1. Okeson J.: Management of temporomandibular disorders and occlusion. Elsevier, 2019.
2. Branco L., Santis T., Alfaya T., Goday C., Fraqoso Y., Bussadori S.: Association between headache and temporomandibular joint disorders in children and adolescents. J Oral Scien. 2013; 55 (1): 39–43.
3. Bonjardim L., Gavido M., Pereira L., Castelo P., Garcia R.: Signs and symptoms of temporoman-dibular disorders in adolescents. Braz Oral Res. 2005; 19 (2): 93–98.
4. Echeverii H.: Evaluation of etiological factor in relation to myofascial pain dysfunction syndrome. Clinical study of 100 students of the University of Antioquia Dental School. Revista de la Facultad de Odontologia Universidad de Antioquia. 1991; 2 (2): 75–87.
5. Fillingim R.B., Ohrbach R., Greenspan J.D., Knott C., Diatchenko L., Dubner R., Bair E., Baraian C., Mack N., Slade G.D., Maixner W.: Psychological factors associated with development of TMD: The OPPERA perspective cohort study. J Pain. 2013; 14: 75–90.
6. Kleinrok M.: Temporomandibular joint dysfunctions. Czelej Editor 2012; 5–23.
7. Auerbach S., Laskin D., Frantsve L., Orr T.: Depression, pain, exposure to stressful life events, and long-term outcomes in temporomandibular disorder patients. J Oral Maxillofac Surg. 2001; 59: 628–633.
8. De Leeuw R., Bertoli E., Schmidt J., Carson C.: Prevalence of traumatic stressors in patient with temporomandibular disorder. J Oral Maxillofac Surg. 2005; 63 (1): 42–50.
9. Martins R., Garbin C., Garcia A.R., Garbin A., Miguel N.: Stress levels and quality of sleep in subjects with temporomandibular joint dysfunction. Rev Odonto Scien. 2010; 25: 32–36.
10. Grey R., Davies S., Quayle A.: The clinical guide to temporomandibular disorders. The clinical guide series. British Dental Journal. 2003: 23–30, 55–60.
11. Osiewicz M., et al.: Research diagnostic criteria for temporomandibular disorders (RDC/TMD) — the polish version af a dual-axis system for diagnosis of TMD RDC/TMD form. J Stoma. 2013; 66 (5): 576–649.
12. Ferreira C., Da Silva M., de Fellicio C.: Orofacial myofunctional disorder in subjects with temporo- mandibular disorder. Cranio: the journal of craniomandibular practice. 2009; 27 (4): 268–274.
13. Hirai K., Ikawa T., Shigeta Y., Shigemoto S., Ogawa T.: Evaluation of sleep bruxism with a novel designed occlusal splint. J Prosthodont Res. 2017; 61 (3): 333–343.
14. Liu F., Steinkeler A.: Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dental Clinics of North America. 2013; 57 (3): 465–479.
15. Glaros A., Williams K., Lauste L.: The role of parafunctions, emotions and stress in predicting facial pain. J Am Dent Assoc. 2005; 136: 451–458.
16. Bertolli E., de Leeuw R., Schmidt J.E., Okeson J.P., Carlson C.R.: Prevalence and impact of post- traumatic stress disorder symptoms in patients with masticatory muscle or temporomandibular joint pain: differences and similarities. J Orofac Pain. 2007; 21: 107–119.
17. Fredricson A., Khodabandehlou F., Weiner C., Naimi-Akbar A., Adami J., Resen A.: Are there early signs that predict development of temporomandibular joint disease? J Oral Sci. 2018; 60 (2): 194–200.
18. Glaros A.G., Hanson A.H., Ryen C.: Headache and oral parafunctional behaviors. Appl Psychophysiol Biofeedback. 2014; 39 (1): 59–66.
19. Pełka P., Williams S., Lipski M., Loster B.W.: Quantitation of condylar position in temporomandibular joint — A methodological study. Folia Med Cracov. 2016; 56 (4): 43–50.
20. Piech J., Pihut M., Kulesa-Mrowiecka M.: Physiotherapy in hypomobility of temporomandibular joints. Folia Med Cracov. 2020; 60 (2): 123–134.

1. Schraufnagel D.E.: Electron microscopy of the lung. New York: Marcel Dekker, CRC Press; 1990.
2. Hogan B., Tata P.R.: Cellular organization and biology of the respiratory system. Nat Cell Biol. 2019. https://doi.org/10.1038/s41556-019-0357-7.
3. Evren E., Ringqvist E., Willinger T.: Origin and ontogeny of lung macrophages: from mice to humans. Immunology. 2020; 160 (2): 126–138.
4. Awad M., Gaber W., Ibrahim D.: Onset of Appearance and Potential Significance of Telocytes in the Developing Fetal Lung. Microsc Microanal. 2019; 25 (5): 1246–1256.
5. Popescu L.M., Gherghiceanu M., Suciu L.C., Manole C.G., Hinescu M.E.: Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011; 345 (3): 391–403.
6. Aleksandrovych V., Pasternak A., Basta P., Sajewicz M., Walocha J.A., Gil K.: Telocytes: facts, speculations and myths (Review article). Folia Med Cracov. 2017; 57 (1): 5–22.
7. Zheng Y., Li H., Manole C.G., Sun A., Ge J., Wang X.: Telocytes in trachea and lungs. J Cell Mol Med. 2011; 15: 2262–2268.
8. Aleksandrovych V., Walocha J.A., Gil K.: Telocytes in female reproductive system (human and animal). J Cell Mol Med. 2016; 20 (6): 994–1000.
9. Díaz-Flores L., Gutiérrez R., Díaz-Flores L.J.R., Goméz M.G., Sáez F.J., Madrid J.F.: Behaviour of telocytes during physiopathological activation. Semin Cell Dev Biol. 2016; 55: 50–61.
10. Hussein M.M., Mokhtar D.M.: The roles of telocytes in lung development and angiogenesis: An immunohistochemical, ultrastructural, scanning electron microscopy and morphometrical study. Dev Biol. 2018; 443 (2): 137–152.
11. Popescu L.M., Faussone-Pellegrini M.S.: TELOCYTES — a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010; 14: 729–740.
12. Ibba-Manneschi L., Rosa I., Manetti M.: Telocyte implications in human pathology: An overview. Biol. 2016; 55: 62–69.
13. Liao Z., Chen Y., Duan C., Zhu K., Huang R., Zhao H., et al.: Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics. 2021; 11 (1): 268–291.
14. Zhaofu L., Dongqing C.: Cardiac Telocytes in Regeneration of Myocardium After Myocardial Infarction. Adv Exp Med Biol. 2016; 913: 229–239.
15. Milia A.F., Ruffo M., Manetti M., Rosa I., Conte D., Fazi M., et al.: Telocytes in Crohn’s disease. Cell Mol Med. 2013; 17 (12): 1525–1536.
16. Ibba-Manneschi L., Rosa I., Manetti M.: Telocytes in Chronic Inflammatory and Fibrotic Diseases. Adv Exp Med Biol. 2016; 913: 51–76.
17. Wolnicki M., Aleksandrovych V., Gil A., Pasternak A., Gil K.: Relation between ureteral telocytes and the hydronephrosis development in children. Folia Med Cracov. 2019; 59 (3): 31–44.
18. Aleksandrovych V., Pasternak A., Gil K.: Telocytes in the architecture of uterine fibroids. Folia Med Cracov. 2019; 59 (4): 33–44.
19. Aleksandrovych V., Białas M., Pasternak A., Bereza T., Sajewicz M., Walocha J., et al.: Identification of uterine telocytes and their architecture in leiomyoma. Folia Med Cracov. 2018; 58 (3): 89–102.
20. Manole C.G., Gherghiceanu M., Simionescu O.J.: Telocyte dynamics in psoriasis. Cell Mol Med. 2015; 19 (7): 1504–1519.
21. Jin L., Wang Z., Qi X.: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature. Medicine (Baltimore). 2018; 97 (52): e13806.
22. Leuenberger P.: [Clinical importance of non-respiratory functions of the lung]. Schweiz Med Wochenschr. 1983; 113 (29): 1006–1010.
23. Wittmann J.: [Respiratory and non-respiratory functions of the lung]. Tierarztl Prax Suppl. 1987; 2: 33–36.
24. Aleksandrovych V., Kurnik-Łucka M., Bereza T., Białas M., Pasternak A., Cretoiu D., Walocha J.A., Gil K.: The Autonomic Innervation and Uterine Telocyte Interplay in Leiomyoma Formation. Cell Transplant. 2019; 28: 619–629.
25. Song D., Cretoiu D., Cretoiu S.M., Wang X.: Telocytes and lung disease. Histol Histopathol. 2016; 31 (12): 1303–1314.
26. Shi L., Dong N., Chen C., Wang X.: Potential roles of telocytes in lung diseases. Semin Cell Dev Biol. 2016; 55: 31–39.
27. Ciechanowicz A.: Stem Cells in Lungs. Adv Exp Med Biol. 2019; 1201: 261–274.
28. Rokicki W., Rokicki M., Wojtacha J., Dżeljijli A.: The role and importance of club cells (Clara cells) in the pathogenesis of some respiratory diseases. Kardiochir Torakochirurgia Pol. 2016; 13 (1): 26–30.
29. Ibba-Manneschi L., Rosa I., Manetti M.: Telocytes in Chronic Inflammatory and Fibrotic Diseases. Adv Exp Med Biol. 2016; 913: 51–76.

1. Jaworek-Troć J., Zarzecki M., Bonczar A., Kaythampillai L.N., Rutowicz B., Mazur M., Urbaniak J., Przybycień W., Piątek-Koziej K., Kuniewicz M., Lipski M., Kowalski W., Skrzat J., Loukas M., Walocha J.: Sphenoid bone and its sinus — anatomo-clinical review of the literature including application to FESS. Folia Med Crac. 2019; 59 (2): 45–59.
2. Jaworek-Troć J., Zarzecki M., Mróz I., Troć P., Chrzan R., Zawiliński J., Walocha J., Urbanik A.: The total number of septa and antra in the sphenoid sinuses — evaluation before the FESS. Folia Med Crac. 2018; 58 (3): 67–81.
3. Jaworek-Troć J., Iwanaga J., Chrzan R., Zarzecki J.J., Żmuda P., Pękala A., Tomaszewska I.M., Tubbs R.S., Zarzecki M.P.: Anatomical variations of the main septum of the sphenoidal sinus and its importance during transsphenoidal approaches to the sella turcica. Transl Res Anat. 2020; 21: 100079.
4. Jaworek-Troć J., Walocha J.A., Chrzan R., Żmuda P., Zarzecki J.J., Pękala A., Depukat P., Kucharska E., Lipski M., Curlej-Wądrzyk A., Zarzecki M.P.: Protrusion of the carotid canal into the sphenoid sinuses: evaluation before endonasal endoscopic sinus surgery. Folia Morph. 2020 (Ahead of print). doi: 10.5603/FM.a2020.0086.
5. Jaworek-Troć J., Walocha J.A., Loukas M., Tubbs R.S., Iwanaga J., Zawiliński J., Brzegowy K., Zarzecki J.J., Curlej-Wądrzyk A., Kucharska E., Burdan F., Janda P., Zarzecki M.P.: Extensive pneumatisation of the sphenoid bone — anatomical investigation of the recesses of the sphenoid sinuses and their clinical importance. Folia Morph. 2020 (Ahead of print). doi: 10.5603/FM.a2020.0120.
6. Jaworek-Troć J., Zarzecki M., Zamojska I., Chrzan R., Curlej-Wądrzyk A., Iwanaga J., Walocha J., Urbanik A.: The height and type of the main septum in the sphenoid sinuses — evaluation before the fess. Folia Med Crac. 2020; 60 (3): 65–74.
7. Jaworek-Troć J., Zarzecki M., Lusina D., Gładysz T., Depukat P., Mazurek A., Twardokęs W., Curlej- Wądrzyk A., Iwanaga J., Walocha E., Chrzan R., Urbanik A.: Incorporation of the sphenoid sinuses’ septum / septa in the carotid canal — evaluation before the fess. Folia Med Crac. 2020; 60 (4): 65–78.
8. Jaworek-Troć J., Zarzecki M., Zamojska I., Iwanaga J., Przybycień W., Mazur M., Chrzan R., Walocha J.A.: The dimensions of the sphenoid sinuses — evaluation before the functional endoscopic sinus surgery. Folia Morph. 2021; 80 (2): 275–282.
9. Jaworek-Troć J., Walocha J.A., Skrzat J., Iwanaga J., Tubbs R.S., Mazur M., Lipski M., Curlej-Wądrzyk A., Gładysz T., Chrzan R., Urbanik A., Zarzecki M.P.: A computed tomography comprehensive evaluation of the ostium of the sphenoid sinus and its clinical significance. Folia Morph. 2021 (Ahead of print). doi: 10.5603/FM.a2021.0063.
10. Tesfaye S., Hamba N., Gerbi A., Negeri Z.: Radio-anatomic variability in the sphenoid sinus pneumatization with its relationship to adjacent anatomical structures and their impact upon reduction of complications following endonasal transsphenoidal surgeries. Transl Res Anat. 2021; 24: 100126.
11. Carvey M., Baek W.K., Hage R.: Bridging the divide: The widening gap between basic science and clinical research. Transl Res Anat. 2021; 24: 100117.
12. Abdullah B.J., Arasaratnam A., Kumar G., Gopala K.: The sphenoid sinuses: computed tomographic assessment of septation, relationship to the internal carotid arteries and sidewall thickness in the Malaysian population. J HK Coll Radiol. 2001; 4: 185–188.
13. Eryilmaz A., Ozeri C., Bayiz U., Samim E., Gocmen H., Akmansu H., Safak M.A., Dursun E.: Functional endoscopic sinus surgery (FESS). Turk J Med Res. 1993; 11 (5): 221–223.
14. Haetinger R.G., Navarro J.A.C., Liberti E.A.: Basilar expansion of the human sphenoidal sinus: an integrated anatomical and computerized tomography study. Eur Radiol. 2006; 16: 2092–2099.
15. Kantarci M., Karasen R.M., Alper F., Onbas O., Okur A., Karaman A.: Remarkable anatomic variantions in paranasal sinus region and their clinical importance. Eur J Radiol. 2004; 50: 296–302.
16. Kazkayasi M., Karadeniz Y., Arikan O.K.: Anatomic variations of the sphenoid sinus on computed tomography. Rhinology. 2005; 43: 109–114.
17. Keast A., Yelavich S., Dawes P., Lyons B.: Anatomical variations of the paranasal sinuses in Polynesian and New Zealand European computerized tomography scans. Otolaryngol Head Neck Surg. 2008; 139: 216–221.
18. Mafee M.F., Chow J.M., Meyers R.: Functional endoscopic sinus surgery: anatomy, CT screening, indications and complications. AJR. 1993; 160: 735–744.
19. Mutlu C., Unlu H.H., Goktan C., Tarhan S., Egrilmez M.: Radiologic anatomy of the sphenoid sinus for intranasal surgery. Rhinology. 2001; 39: 128–132.
20. Perez-Pinas I., Sabate J., Carmona A., Catalina-Herrera C.J., Jimenez-Castellanos J.: Anatomical variations in the human paransal sinus region studied by CT. J Anat. 2000; 197: 221–227.
21. Terra E.R., Guedes F.R., Manzi F.R., Boscolo F.N.: Pneumatization oft he sphenoid sinus. Dentomaxillofacial Radiology. 2006; 35: 47–49.
22. Stecco A., Boccafoschi F., Falaschi Z., Mazzucca G., Carisio A., Bor S., Valente I., Cavalieri S., Carriero A.: Virtual dissection table in diagnosis and classification of Le Fort fractures: A retrospective study of feasibility. Transl Res Anat. 2020; 18: 100060.
23. Sinha S., Shetty A., Nayak K.: The morphology of Sella Turcica in individuals with different skeletal malocclusions — a cephalometric study. Transl Res Anat. 2020; 18: 100054.
24. Becker D.G.: The minimally invasive, endoscopic approach to sinus surgery. Journal of Long-Term Effects of Medical Implants. 2003; 13 (3): 207–221.
25. Bogusławska R.: Badanie zatok przynosowych metoda tomografii komputerowej dla celów chirurgii endoskopowej. Warszawa 1995.
26. Anusha B., Baharudin A., Philip R., Harvinder S., Mohd Shaffie B., Ramiza R.R.: Anatomical variants of surgically important landmarks in the sphenoid sinus: a radiologic study in Southeast Asian patients. Surg Radiol Anat. 2015; 37: 1182–1190.
27. Tan H.K.K., Ong Y.K.: Sphenoid sinus: an anatomic and endoscopic study in Asian cadavers. Clinical Anatomy. 2007; 20: 745–750.
28. Battal B., Akay S., Karaman B., Hamcan S., Akgun V., Sari S., Bozlar U., Tasar M.: The relationship between the variations of sphenoid sinus and nasal septum. Gulhane Tip Derg. 2014; 56: 232–237.
29. Hammer G., Radberg C.: The sphenoidal sinus. Acta Radiologica. 1961; 56 (6): 401–422.
30. Elwany S., Yacout Y.M., Talaat M., El-Nahass M., Gunied A., Talaat M.: Surgical anatomy of the sphenoid sinus. The Journal of Laryngology and Otology. 1983; 97: 227–241.
31. Kinnman J.: Surgical aspects of the anatomy of the sphenoidal sinuses and the sella turcica. J Anat. 1977; 124 (3): 541–553.
32. Lupascu M., Comsa Gh., Zainea V.: Anatomical variations of the sphenoid sinus — a study of 200 cases. ARS Medica Tomitana. 2014; 2 (77): 57–62.
33. Lee J.-Ch., Chuo P.-I., Hsiung M.-W.: Ischemic optic neuropathy after endoscopic sinus surgery: a case report. Eur Arch Otorhinolaryngol. 2003; 260: 429–431.
34. Dundar R., Kulduk E., Soy F.K., Aslan M., Kilavuz A.E., Sakarya E.U., Yazici H., Eren A.: Radiological evaluation of septal bone variations in the sphenoid sinus. J Med Updates. 2014; 4 (1): 6–10.
35. Kayalioglu G., Erturk M., Varol T.: Variations in sphenoid sinus anatomy with special emphasis on pneumatization and endoscopic anatomic distances. Neurosciences. 2005; 10 (1): 79–84.
36. Sareen D., Agarwail A.K., Kaul J.M., Sethi A.: Study of sphenoid sinus anatomy in relation to endoscopic surgery. Int J Morphol. 2005; 23 (3): 261–266.
37. Tan H.M., Chong V.F.H.: CT of the paranasal sinuses: normal anatomy, variations and pathology. CME Radiology. 2001; 2 (3): 120–125.
38. Cope V.Z.: The internal structure of the sphenoidal sinus. J Anat. 1917; 51 (2): 127–136. 39. Yune H.Y., Holden R.W., Smith J.A.: Normal variations and lesions of the sphenoid sinus. AM J Roentgenol Radium Ther Nucl Med. 1975; 124 (1): 129–138.
40. Hayashi Y., Kita D., Iwato M., Fukui I., Sasagawa Y., Oishi M., Tachibana O., Nakada M.: Midline dural filum of the sellar floors: its relationship to the septum attachment to the sellar floor and the ossification in the sphenoid sinus. Clin Neurol Neurosurg. 2016; 147: 53–58.

1. Adorini L., Penna G.: Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008; 4: 404–412.
2. Pilz S., Tomaschitz A., Obermayer-Pietsch B., Dobnig H., Pieber T.R.: Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009; 29: 3699–4704.
3. Pilz S., März W., Wellnitz B., et al.: Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography. J Clin Endocrinol Metab. 2008; 93: 3927–3935.
4. Shapira Y., Agmon-Levin N., Shoenfeld Y.: Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol. 2010; 38: 169–177.
5. Maruotti N., Cantatore F.P.: Vitamin D and the Immune System. J Rheumatol. 2010; 37: 491–495.
6. Kamen D.L., Aranow C.: The Link Between Vitamin D Deficiency and Systemic Lupus Erythema-tosus. Curr Rheumatol Rep. 2008; 10: 273–280.
7. Cutolo M.: Vitamin D and autoimmune rheumatic diseases. Rheumatology. 2009; 48: 210–212.
8. Hyppönen E.: Vitamin D and increasing incidence of type 1 diabetes — evidence for an association? Diabetes Obes Metab. 2010; 12: 737–743.
9. Ruiz-Irastorza G., Gordo S., Olivares N., Egurbide MV., Aguirre C.: Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care and Res. 2010; 62: 1160–1165.
10. Munger K.L., Zhang S.M., O’Reilly E., et al.: Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004; 62: 60–65.
11. Vaidya B., Chakera A.J., Dick C.: Addison’s disease. BMJ (Clinical research ed). 2009; 339:b2385.
12. Barthel A., Benker G., Berens K., et al.: An Update on Addison’s Disease. Exp Clin Endocrinol Diabetes. 2019; 127: 165–170.
13. Jeffery L.E., Burke F., Mura M., et al.: 1,25-Dihydroxyvitamin D 3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3. J Immunol. 2009; 183: 5458–5467.
14. Prietl B., Treiber G., Pieber T.R., Amrein K.: Vitamin D and immune function. Nutrients. 2013; 5: 2502–2521.
15. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al.: Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911–1930.
16. Chaudhary S., Dutta D., Kumar M., et al.: Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: An open-labeled randomized controlled trial. Indian J Endocrinol Metab. 2016; 20: 391–398.
17. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M.: Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet. 2001; 358: 1500–1503.
18. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A.: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006; 296: 2832–2838.
19. Lee Y.H., Bae S.C.: Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: A meta-analysis. Clin Exp Rheumatol. 2016; 34: 827–833.
20. Zella J.B., McCary L.C., DeLuca H.F.: Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003; 417: 77–80.
21. Chen W., Lin H., Wang M.: Immune intervention effects on the induction of experimental autoimmune thyroiditis. J Huazhong Univ Sci Technolog Med Sci. 2002; 22: 343–345, 354.
22. Erichsen M.M., Løvås K., Skinningsrud B., et al.: Immune intervention effects on the induction of experimental autoimmune thyroiditis. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009; 94: 4882–4890.
23. Betterle C., Dal Pra C., Mantero F., Zanchetta R.: Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002; 23: 327–364.
24. Yu L., Brewer K.W., Gates S., et al.: DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison’s disease. J Clin Endocrinol Metab. 1999; 84: 328–335.
25. Baker P.R., Baschal E.E., Fain P.R., et al.: Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison’s disease. J Clin Endocrinol Metab. 2010; 95: E263–70.
26. Mitchell A.L., Pearce S.H.S.: Autoimmune Addison disease: pathophysiology and genetic complexity. Nat Rev Endocrinol. 2012; 8: 306–316. 27. Aranow C.: Vitamin D and the immune system. J Investig Med. 2011; 59: 881–886.
28. Penna-Martinez M., Filmann N., Bogdanou D., et al.: High-dose vitamin D in Addison’s disease regulates T-cells and monocytes: A pilot trial. Nutrition (Burbank, Los Angeles County, Calif). 2018; 49: 66–73.
29. Pani M.A., Seissler J., Badenhoop K.: Vitamin D receptor genotype is associated with Addison’s disease. Eur J Endocrinol. 2002; 147: 635–640.
30. Demir K., Kattan W.E., Zou M., et al.: Novel CYP27B1 gene mutations in patients with vitamin D-dependent rickets type 1A. PLoS ONE. 2015; 10: e0131376.
31. Fichna M., Żurawek M., Januszkiewicz-Lewandowska D., et al.: Association of the CYP27B1 C(- 1260) A polymorphism with autoimmune Addison’s disease. Exp Clin Endocrinol Diabetes. 2010; 118: 544–549.
32. Jennings C.E., Owen C.J., Wilson V., Pearce S.H.S.: A haplotype of the CYP27B1 promoter is associated with autoimmune Addison’s disease but not with Graves’ disease in a UK population. J Mol Endocrinol. 2005; 34: 859–863.
33. Bellastella G., Maiorino M.I., Petrizzo M., et al.: Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes? J Endocrinol Invest. 2015; 38: 629–633.
34. Harms L.R., Burne T.H.J., Eyles D.W., McGrath J.J.: Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011; 25: 657–669.
35. Cui X., Pelekanos M., Liu P.Y., Burne T.H.J., McGrath J.J., Eyles D.W.: The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience. 2013; 236: 77–87.
36. Meeusen R., Watson P., Hasegawa H., Roelands B., Piacentini M.F.: Central fatigue: The serotonin hypothesis and beyond. Sports Med. 2006; 36: 881–909.
37. Kaneko I., Sabir M.S., Dussik C.M., et al.: 1,25-DihydroxyVitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: Implication for behavioral influences of Vitamin D. FASEB J. 2015; 29: 4023–4035.
38. Sinha A., Hollingsworth K.G., Ball S., Cheetham T.: Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab. 2013; 98: E509–E513.
39. Ryan Z.C., Craig T.A., Folmes C.D., et al.: 1α,25-dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J Biol Chem. 2016; 291: 1514–1528.
40. Tomlinson P.B., Joseph C., Angioi M.: Effects of vitamin D supplementation on upper and lower body muscle strength levels in healthy individuals. A systematic review with meta-analysis. J Sci Med Sport. 2015; 18: 575–580.
41. Kamen D.L., Oates J.: A pilot randomized, controlled trial of vitamin D repletion to determine if endothelial function improves in patients with systemic lupus erythematosus. Am J Med Sci. 2015; 350: 302–307.
42. Lima G.L., Paupitz J., Aikawa N.E., Takayama L., Bonfa E., Pereira R.M.R.: Vitamin D Supplemen-tation in Adolescents and Young Adults with Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo- Controlled Trial. Arthritis Care Res. 2016; 68: 91–98.
43. Beckmann Y., Türe S., Duman S.U.: Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients. EPMA Journal. 2020; 11: 65–72.
44. Nowak A., Boesch L., Andres E., et al.: Effect of vitamin D3 on self-perceived fatigue A double-blind randomized placebo-controlled trial. Medicine. 2016; 95: 1–6.
45. van der Valk E.S., Smans L.C., Hofstetter H., et al.: Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison’s disease. Clin Endocrinol (Oxf). 2016; 85: 354–360.
46. Bleicken B., Hahner S., Loeffler M., et al.: Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2010; 72: 297–304.
47. Riedel M., Wiese A., Schürmeyer T.H., Brabant G.: Quality of life in patients with Addison’s disease: effects of different cortisol replacement modes. Exp Clin Endocrinol. 1993; 101: 106–111.
48. Bergthorsdottir R., Leonsson-Zachrisson M., Odén A., Johannsson G.: Premature Mortality in Patients with Addison’s Disease: A Population-Based Study. J Clin Endocrinol Metab. 2006; 91: 4849–4853.
49. Hahner S., Loeffler M., Fassnacht M., et al.: Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis. J Clin Endocrinol Metab. 2007; 92: 3912–3922.
50. Laureti S., Vecchi L., Santeusanio F., Falorni A.: Is the prevalence of Addison’s disease under-estimated? J Clin Endocrinol Metab. 1999; 84: 1762.
51. Løvås K., Husebye E.S.: High prevalence and increasing incidence of Addison’s disease in western Norway. Clin Endocrinol (Oxf). 2002; 56: 787–791.
52. Jordan B., Uer O., Buchholz T., Spens A., Zierz S.: Physical fatigability and muscle pain in patients with Hashimoto thyroiditis. J Neurol. 2021 Jan 28. doi: 10.1007/s00415-020-10394-5.

1. Shaikh N., Hoberman A., Wise B., et al.: Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life? Pediatrics. 2003 Nov; 112 (5): 1134–1137.
2. Halachmi S., Farhat W.A.: Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux. Adv Urol. 2008; 2008: 828275.
3. Aydoğdu O., Burgu B., Teber S., et al.: A challenging review of childhood incontinence: rare complications of dysfunctional elimination syndrome in an epileptic boy. Turk J Pediatr. 2011 Jan– Feb; 53 (1): 100–103.
4. Von Gontard A., Hollmann E.: Comorbidity of functional urinary incontinence and encopresis: somatic and behavioral associations. J Urol. 2004 Jun; 171 (6 Pt 2): 2644–2647.
5. Curran M.J., Kaefer M., Peters C., Logigian E., Bauer S.B.: The overactive bladder in childhood: long- term results with conservative management. J Urol. 2000 Feb; 163 (2): 574–577.
6. Hadjizadeh N., Motamed F., Abdollahzade S., Rafiei S.: Association of voiding dysfunction with functional constipation. Indian Pediatr. 2009 Dec; 46 (12): 1093–1095. Epub 2009 Apr 1.
7. Klijn A.J., Asselman M., Vijverberg M.A., et al.: The diameter of the rectum on ultrasonography as a diagnostic tool for constipation in children with dysfunctional voiding. J Urol. 2004 Nov; 172 (5 Pt 1): 1986–1988.
8. Wein A.J., Kavoussi L.R., Campbell M.F.: Urology Cambell-Walsh, 10th ed. Saunders Elsevier: 2012; 3418–3420.
9. O’Regan S., Yazbeck S.: Constipation: a cause of enuresis, urinary tract infection and vesico-ureteral reflux in children. Med Hypotheses. 1985 Aug; 17 (4): 409–413.
10. O’Regan S., Yazbeck S., Schick E.: Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol. 1985 Mar; 23 (3): 152–154.
11. Ab E., Schoemaker M., Van Empelen R.: Paradoxical movement of the pelvic floor in dysfunctional voiding and the results of biofeedback training. Br J Urol Int. 2002; 89: 48.
12. Patoulias I.: Voiding disturbance in childhood. 1st ed. Parisianos, Athens: 2011; 58– 59. ISBN 978- 960-394-723-3.
13. Loening-Baucke V.: Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997 Aug; 100 (2 Pt 1): 228–232.
14. Chase J., Austin P., Hoebeke P., McKenna P.: International Children's Continence Society. The management of dysfunctional voiding in children: a report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2010 Apr; 183 (4): 1296–1302.
15. Hoebeke P., Van Laecke E., Van Camp C., Raes A., Van De Walle J.: One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int. 2001 Apr; 87 (6): 575–580.
16. Herndon C.D., Decambre M., McKenna P.H.: Interactive computer games for treatment of pelvic floor dysfunction. J Urol. 2001 Nov; 166 (5): 1893–1898.
17. Hansson S., Hjalmas K., Jodal U., Sixt R.: Lower urinary tract dysfunction in girls with untreated asymptomatic or cover bacteriuria. J Urol. 1990; 143: 333–336.
18. Issenman R.M., Filmer R.B., Gorski P.A.: A review of bowel and bladder control development in children: how gastrointestinal and urologic conditions relate to problems in toilet training. Pediatrics 1999; 103: 1346–1352.
19. Regan S.O., Schick E., Hamburger B., Yazbeck S.: Constipation associated with vesicoureteral reflux. Urol. 1986; 28: 394–396.
20. Chen J.J., Mao W., Homayoon K., Steinhardt G.F.: A multivariate analysis of dysfunction elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol. 2004; 171: 1907–1910.
21. Naseer S.R., Steinhardt G.F.: New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation. J Urol. 1997 Aug; 158 (2): 566–568.
22. Mulders M.M., Cobussen-Boekhorst H., de Gier R.P., Feitz W.F., Kortmann B.B.: Urotherapy in children: quantitative measurements of daytime urinary incontinence before and after treatment according to the new definitions of the International Children’s Continence Society. J Pediatr Urol. 2011 Apr; 7 (2): 213–218.
23. Nevéus T., Von Gontard A., Hoebeke P., et al.: The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006 Jul; 176 (1): 314–324.
24. Farhat W., Bägli D.J., Capolicchio G., et al.: The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol. 2000 Sep; 164 (3 Pt 2): 1011–1015.
25. Bower W.F., Yip S.K., Yeung C.K.: Dysfunctional elimination symptoms in childhood and adulthood. J Urol. 2005 Oct; 174 (4 Pt 2): 1623–1627; discussion 1627–1628.
26. Vereecken R.L., Proesmans W.: Urethral instability as an important element of dysfunctional voiding. J Urol. 2000; 163: 585–588.
27. Dede O., Sakellaris G.: Daytime urinary incontinence. Essentials in Pediatr Urol. 2012; 57–68.
28. Desantis D.J., Leonard M.P., Preston M.A., Barrowman N.J., Guerra L.A.: Effectiveness of biofeedback for dysfunctional elimination syndrome in pediatrics: a systematic review. J Pediatr Urol. 2011 Jun; 7 (3): 342–348.
29. Dyer L.L., Franco I.: Botulinum Toxin-A Therapy in pediatric Urology: Indications for the Neurogenic and Non-Neurogenic Neurogenic Bladder. Scientific World J. 2009; 9: 1300–1305.
30. Kroll P., Jankowski A., Soltysiak J., et al.: Botulinum toxin-A injections in children with neurogenic bladder. Nephroourol. 2011; 3: 125–128.
31. Carr L.K.: Botulinum toxin A should not be first-line therapy for overactive bladder. Can Urol Assoc J. 2011 Jun; 5 (3): 204–205.
32. Steele S.S.: Botulinum toxin A: First-line therapy for idiopathic detrusor over activity. Can Urol Assoc J. 2011; 5: 207–209.
33. Barroso U. Jr, Tourinho R., Lordêlo P., Hoebeke P., Chase J.: Electrical stimulation for lower urinary tract dysfunction in children: a systematic review of the literature. Neurourol Urodyn. 2011 Nov; 30 (8): 1429–1436.
34. Lordêlo P., Soares P.V., Maciel I., Macedo A. Jr, Barroso U. Jr.: Prospective study of transcutaneous parasacral electrical stimulation for overactive bladder in children: long-term results. J Urol. 2009 Dec; 182 (6): 2900–2904.

1. World Health Organization. Salmonella (non-typhoidal). 20 Feb. 2017. Available from: www.who.int/ news-room/fact-sheets/detail/salmonella-(non-typhoidal).
2. Hayden H.S., Matamouros S., Hager K.R., et al.: Genomic analysis of Salmonella enterica serovar Typhimurium characterizes strain diversity for recent U.S. Salmonellosis cases and identifies mutations linked to loss of fitness under nitrosative and oxidative stress. mBio. 2016; 7 (2): e00154.
3. Kulikovskiy A.: Salmonellosis: monitoring is necessary / Zhivotnovodstvo Rossii. 2016; 1: 63‒64. (Russian)
4. Henao O.L., Jones T.F., Vugia D.J., et al.: Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet 2015 Surveillance Report (Final Data). Emerg Infect Dis. 2015; 21 (9): 1529–1536.
5. Knegt L.V., Pires S.M., Hald T.: Attributing foodborne salmonellosis in humans to animal reservoirs in the European Union using a multi-country stochastic model. Epidemiol Infect. 2015; 143 (6): 1175‒1186.
6. Bergey’s Manual of systematic Bacteriology: 1986. Williams & Wilkins, Baltimore-Hong Kong- London–Sydney. Vol. 1, 2, 3.
7. Zubkov M.N., Menshikov D.D., Gugutsidze E.N., et al.: Microbiological diagnosis of mixed anaerobic- aerobic infections in surgery. Antibiotiki i himioterapiya. 1995; 40 (2): 46‒50. (Russian)
8. World Health Organization. Salmonella (non-typhoidal). 20 Feb. 2017. Available from: www.who.int/en/news-room/fact-sheets/detail/salmonella-(non-typhoidal)
9. Malysh N., Chemych M., Zadorozhna V., Podavalenko A., Birukova S.: Diarrhea infections in North- Eastern Ukraine: evolution of epidemic process. Bangladesh Journal of Medical Science. 2020; 19 (3): 420‒426.
10. Whiley H., Ross K.: Salmonella and Eggs: From Production to Plate. J Environ Res Public Health. 2015; 12 (3): 2543‒2556.
11. He F., Zhu X.P., Zhu B.P., Ma H.L.: Study on an outbreak of food poisoning caused by Salmonella blegdam. Zhonghua Liu Xing Bing Xue Za Zhi. 2011; 32 (7): 697‒699. (Chinese)
12. Malysh N.G., Chemich N.D., Zaritskiy A.M.: Incidence, predisposing risk factors for the development and spread of acute intestinal infections in the north-eastern region of Ukraine. Gigiena i sanitariya. 2016; 95 (3): 287‒292. (Russian)
13. Sergevnin V.I., Ladeyschikova Yu.I., Devyatkov M.Yu., Sarmometov E.V.: Assessment of the epidemiological significance and conditions of microbial contamination of vegetable salads as transmission factors of pathogens of acute intestinal infections in modern conditions. Epidemiologiya i infektsionnyie bolezni. 2011; 1: 31‒35. (Russian)
14. Seregin I.G., Butko M.P., Vasilev D.A.: Veterinary and sanitary control of meat of compelled animals. Veterinariya. 2012; 5: 3‒9. (Russian)
15. Belyaeva Yu.N.: Some epidemiological aspects of digestive diseases at the regional level // Materialyi VII Mezhdunarodnoy (XVI Vserossiyskoy) Pirogovskoy nauchnoy meditsinskoy konferentsii studentov i molodyih uchYonyih, Moskva, 2012. (Russian)
16. Antipov M.O., Mindlina A.Ya.: Digestive diseases of an infectious and non-infectious nature. Epidemiological relationship. Epidemiologiya i vaktsinoprofilaktika. 2019; 18 (1): 55‒65. (Russian)
17. Sergevnin V.I.: Acute intestinal infections. Waterway transmission of pathogens. Vrach. 2013; 7: 74‒76. (Russian)

1. Centrala NFZ DA i I. NFZ o Zdrowiu, Choroba Niedokrwienna Serca.; 2020. https://www.nfz.gov.pl/aktualnosci/aktualnosci-centrali/nowy-raport-nfz-depresja,7593.html.
2. Bandosz P., O’Flaherty M., Drygas W., et al.: Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: Modelling study. BMJ. 2012; 344 (7842). doi: 10.1136/bmj.d8136.
3. Brodie B.R., Kissling G.: Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Circulation. 2000; 102 (4): E29– 30. doi: 10.1161/01.cir.102.4.e29.
4. Swanoski M.T., Lutfiyya M.N., Amaro M.L., Akers M.F., Huot K.L.: Knowledge of heart attack and stroke symptomology: A cross-sectional comparison of rural and non-rural US adults. BMC Public Health. 2012; 12 (1). doi: 10.1186/1471-2458-12-283.
5. Piepoli M.F., Hoes A.W., Agewall S., et al.: 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016; 37 (29): 2315–2381. doi: 10.1093/eurheartj/ehw106.
6. Waśniowska A., Kopeć G., Szafraniec K., et al.: Assessment of knowledge on cardiovascular disease risk factors by postal survey in residents of Małopolska Voivodeship. Małopolska CArdiovascular PReventive Intervention Study (M-CAPRI). Ann Agric Environ Med. 2017; 24 (2): 201–206. doi: 10.5604/12321966.1228400.
7. Homko C.J., Santamore W.P., Zamora L., et al.: Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease. J Cardiovasc Nurs. 2008; 23 (4): 332–337. doi: 10.1097/01.JCN.0000317432.44586.aa.
8. Kopec G., Sobien B., Podolec M., et al.: Knowledge of a patient-dependant phase of acute myocardial infarction in Polish adults: The role of physician’s advice. Eur J Public Health. 2011; 21 (5): 603–608. doi: 10.1093/eurpub/ckq110.
9. Birnbach B., Höpner J., Mikolajczyk R.: Cardiac symptom attribution and knowledge of the symptoms of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2020; 20 (1). doi: 10.1186/s12872-020-01714-8.
10. Lozzi L., Carstensen S., Rasmussen H., Nelson G.: Why do acute myocardial infarction patients not call an ambulance? An interview with patients presenting to hospital with acute myocardial infarction symptoms. Intern Med J. 2005; 35 (11): 668–671. doi: 10.1111/j.1445-5994.2005.00957.x.
11. Legutko J., Niewiara L., Bartus S., et al.: Decline in the number of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Poland during the coronavirus disease 2019 pandemic. Kardiol Pol. 2020; 78 (6): 574–576. doi: 10.33963/KP.15393.
12. Rattka M., Dreyhaupt J., Winsauer C., et al.: Effect of the COVID-19 pandemic on mortality of patients with STEMI: A systematic review and meta-analysis. Heart. 2021; 107 (6): 482–487. doi: 10.1136/heartjnl-2020-318360.
13. Siudak Z., Grygier M., Wojakowski W., et al.: Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions. Catheter Cardiovasc Interv. 2020; 96 (6): E568–E575. doi: 10.1002/ccd.29134.
14. Azul Freitas A., Baptista R., Gonçalves V., et al.: Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data. Rev Port Cardiol. 2021. doi: 10.1016/j.repc.2020.10.012.
15. Perrin N., Iglesias Juan F., Florian R., et al.: Impact of the COVID-19 pandemic on acute coronary syndromes. Swiss Med Wkly. 2020; 150 (51). doi: 10.4414/smw.2020.20448.
16. Aldujeli A., Hamadeh A., Briedis K., et al.: Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic. Cardiol Res. 2020; 11 (6): 386–391. doi: 10.14740/cr1175.
17. Grech N., Xuereb R., England K., Xuereb R.G., Caruana M.: When the patients stayed home: the impact of the COVID-19 pandemic on acute cardiac admissions and cardiac mortality in Malta. J Public Heal. 2021. doi: 10.1007/s10389-021-01520-2.

1. Nilesh K., Vande A. V.: Mucormycosis of maxilla following tooth extraction in immunocompetent patients: reports and review. J Clin Exp Dent. 2018; 10 (3): e300.
2. Paultauf A.: Mycosis mucorina. Ein Beitrag zur Kenntniss der menschlichen Fadenpilzerkrankungen. Arch Path Anat. 1885, 102 (3): 543–564.
3. Cornely O. A., Alastruey-Izquierdo A., Arenz D., et al.: Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infect Dis. 2019; 19 (12): e405–e421.
4. Sikora M., Małecka M., Stąpor A., et al.: Mucormycosis of the maxillary sinus in an immunocompetent woman with oro-antral fistula — a case report. Pomeranian Journal of Life Sciences. 2021; 67 (1): 32– 37.
5. Rawlani S.S., Siddiqui A., Reza M., et al.: Black Fungus Mucormycosis, Epidemiology, Etiopathogenesis, Clinical Diagnosis, Histopathology and its Management — A Review. Int J Med Dent Res. 2021; 1 (2): 01–08.
6. Serris A., Danion F., Lanternier F.: Disease entities in mucormycosis. Journal of Fungi. 2019; 5 (1): 23.
7. Ahmadikia K., Hashemi S.J., Khodavaisy S., et al.: The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021; 64 (8): 798–808.
8. Prakash H., Chakrabarti A.: Global epidemiology of mucormycosis. Journal of Fungi. 2019; 5 (1): 26.
9. Jeyaraj P.: Sino-Maxillary Mucormycosis of Iatrogenic Etiology in an Immunocompetent Patient- Importance of Early Diagnosis and Prompt Management. Journal of Infectious Diseases & Case Reports. 2021; 2 (1): 1–8. https://doi.org/10.47363/JIDSCR/2021.
10. Kiralj A., Nalić B., Brajković D.: Management of fulminant mucormycosis of maxillary sinus and orbit with uncontrolled diabetic. Srpski arhiv za celokupno lekarstvo. 2021; 149 (3–4): 225–228. https://doi.org/10.2298/SARH200604015K.
11. Viterbo S., Fasolis M., Garzino-Demo P., et al.: Management and outcomes of three cases of rhinocerebral mucormycosis. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod. 2011; 112 (6): e69–e74.
12. Martínez-Herrera E., Julián-Castrejón A., Frías-De-León M.G., et al.: Rhinocerebral mucormycosis to the rise? The impact of the worldwide diabetes epidemic. Anais Brasileiros de Dermatologia. 2021; 96: 196–199.
13. Bansal D., Pandey A.K., Bhardwaj A., et al.: Extra-Rhino Cerebral Manifestations of Mucormycosis in Head and Neck Region: An Insight. Indian Journal of Otolaryngology and Head & Neck Surgery. 2021; 1–6. https://doi.org/10.1007/s12070-021-02440-z.
14. Honavar S.G.: Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito- Cerebral Mucormycosis in the Setting of COVID-19. Indian Journal of Ophthalmology. 2021; 69 (6): 1361–1365. https://doi.org/10.4103/ijo.IJO_1165_21.
15. Prabhu S., Alqahtani M., Al Shehabi M.: A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature. Journal of Infection and Public Health. 2018; 11 (3): 301–303.
16. Karthik S., Shanmugam A., Dhinakaran E.C., et al.: Mucormycosis. Case report and literature review. Hel Arch Oral & Max Fac Surg. 2021; 21 (1): 37–41.
17. Srivastava A., Mohpatra M., Mahapatra A.: Maxillary fungal osteomyelitis: A review of literature and report of a rare case. Annals of Maxillofacial Surgery. 2019; 9 (1): 168.
18. Ketenci İ, Ünlü Y., Kaya, et al.: Rhinocerebral mucormycosis: Experience in 14 patients. The Journal of Laryngology & Otology. 2011; 125 (8): E3. doi: 10.1017/S0022215111000843.
19. Prakash H., Chakrabarti A.: Epidemiology of Mucormycosis in India. Microorganisms. 2021; 9: 523.
20. Nishanth D.G., Anitha D.N., Babu D.N.A., et al.: Mucormycosis — A Review. European Journal of Molecular & Clinical Medicine. 2020; 7 (3): 1786–1791.
21. Suganya R., Malathi N., Karthikeyan V., et al.: Mucormycosis: a brief review. J Pure Appl Microbiol. 2019; 13 (1): 161–165.
22. Maini A., Tomar G., Khanna D., et al.: Sino-orbital mucormycosis in a COVID-19 patient: A case report. Int J Surg Case Rep. 2021; 82: 105957.
23. Pandiar D., Kumar N.S., Anand R., et al.: Does COVID 19 generate a milieu for propagation of mucormycosis? Med Hypotheses. 2021 Jul; 152: 110613. doi: 10.1016/j.mehy.2021.110613. PMID: 34087613; PMCID: PMC8152198.
24. Doni B.R., Peerapur B.V., Thotappa L.H., et al.: Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian J Dent Res. 2011; 22 (2): 331.
25. Fouad Y.A., Abdelaziz T.T., Askoura A., et al.: Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic. Front Med (Lausanne). 2021; 8: 645270. Published 2021 May 28. doi: 10.3389/fmed.2021.645270.
26. Banerjee M., Pal R., Bhadada S.K.: Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. 2021 Jun 8. doi: 10.1136/postgradmedj-2021-140537. Epub ahead of print. PMID: 34103372.
27. Reddy S.G., Kumar K.K., Sekhar C.P., et al.: Oral Mucormycosis: Need for early diagnosis! J NTR Univ Health Sci. 2014; 3: 145–147.
28. Dadhich A., Nilesh K., Patil R., et al.: Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Reports CP. 2021; 14 (1): e239199.
29. Godinho G., Abreu I., Alves G., et al.: Orbital Apex Syndrome due to Orbital Mucormycosis after Teeth Infection: A Successful Case Report. Case Reports in Ophthalmology. 2021; 12 (1): 110–115.
30. Nicolatou-Galitis O., Sachanas S., Drogari-Apiranthitou M., et al.: Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case report and literature review. JMM Case Reports. 2015; 2 (1): e000014.
31. Lupoi D., Preda M.: Fungal rhinosinusitis between regular infection and aggressive life-threatening disease. Journal of Contemporary Clinical Practice. 2020; 6 (2): 86–92.
32. Santosh A.B.R., Muddana K., Bakki S.R.: Fungal infections of oral cavity: diagnosis, management, and association with COVID-19. SN Compr Clin Med. 2021; 3: 1373–1384.
33. Bonifaz A., Tirado-Sánchez A., Paredes-Farrera F., et al.: Oral involvement in mucormycosis. A retrospective study of 55 cases. Enferm Infecc y Microbiol Clín. (English ed.) 2020. S0213-005X (20) 30293-7.
34. Gupta D.K., Gupta D.K., Gupta N.: Dental Complications After Covid-19 Mucormycosis?? Under-standing The Pathophysiology. Guident. 2021 Mar; 14 (4): 26–29.
35. Kwak E.J., Kim D.J., Nam W., Park W.: Mucormycosis in the Jaw: A Report of 2 Cases and Literature Review. Oral Health & Preventive Dentistry. 2020; 18 (1): 1011–1016. https://doi.org/10.3290/j.ohpd.a45522.
36. Brunet K., Rammaert B.: Mucormycosis treatment: Recommendations, latest advances, and perspectives. J Mycol Méd. 2020; 30 (3): 101007.
37. Panneerselvam K., Kumar M.S., Karthikeyan A.: Recurrent mucormycosis — Better understanding of treatment and management. J Family Med Prim Care. 2020; 9 (12): 6279.
38. Gaur V., Patel K., Pałka Ł.: An implant-supported prosthetic rehabilitation of a patient with a bilateral subtotal maxillectomy defect secondary to rhino-orbital-cerebral mucormycosis: A clinical report of a graftless approach. J Prosthet Dent. 2021 Feb 4: S0022-3913(21)00005-6. doi: 10.1016/j.prosdent.2020.12.022.Epub ahead of print. PMID: 33551135.